title: Bullous fixed drug eruption to etoricoxib--further evidence of intraepidermal CD8+ T cell involvement.
authors.forename: Ana Filipa
authors.initials: AF
authors.lastname: Duarte
authors.forename: Osvaldo
authors.initials: O
authors.lastname: Correia
authors.forename: Rosa
authors.initials: R
authors.lastname: Azevedo
authors.forename: Maria
authors.initials: M
authors.lastname: do Carmo Palmares
authors.forename: Luís
authors.initials: L
authors.lastname: Delgado
mesh_terms: D000368:Aged; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D052246:Cyclooxygenase 2 Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000077613:Etoricoxib; D006801:Humans; D008297:Male; D011725:Pyridines / Q000008:administration & dosage / Q000009:adverse effects*; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000378:metabolism; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D011725:Pyridines; D013450:Sulfones; D000077613:Etoricoxib